Recursion Pharmaceuticals, Inc. RXRX Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s accrued manufacturing costs?
- Recursion Pharmaceuticals, Inc. (RXRX) reported accrued manufacturing costs of $14.57M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s accrued manufacturing costs changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s accrued manufacturing costs decreased by 35.1% year-over-year, from $22.46M to $14.57M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s accrued manufacturing costs?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s accrued manufacturing costs has grown at a 59.4% compound annual growth rate (CAGR), from $3.09M to $31.77M.